188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma-Reference-Cited by-同舟云学术

188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma

Published:2004-10 Issue:10 Volume:25 Page:1007-1013
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:Nuclear Medicine Communications

Author:

Garin Etienne,Denizot Benoit,Noiret Nicolas,Lepareur Nicolas,Roux Jerome,Moreau Myriam,Herry Jean-Yves,Bourguet Patrick,Benoit Jean-Pierre,Lejeune Jean-Jacques

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference37 articles.

1. Epidemiology of Primary Liver Cancer

2. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients

3. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian Experience

4. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study);Cancers;2023-04-11

2. Organometallic and coordination rhenium compounds and their potential in cancer therapy;Coordination Chemistry Reviews;2019-08

3. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization;European Journal of Nuclear Medicine and Molecular Imaging;2019-02-04

4. Mechanism of Action, Pharmacokinetics, Efficacy, and Safety of Transarterial Therapies Using Ethiodized Oil: Preclinical Review in Liver Cancer Models;Journal of Vascular and Interventional Radiology;2018-03

5. Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Hepatic Cancer;Radiopharmaceuticals for Therapy;2016